Jazz Pharmaceuticals Inc (ticker: JAZZ, exchange: NASDAQ Global Market (.O))
News Release -
Jazz Pharmaceuticals to Present at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference
PALO ALTO, Calif., Aug 06, 2010 /PRNewswire via COMTEX/ --
Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that Bruce Cozadd, the company's Chairman and Chief Executive Officer, will present at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference on Thursday, August 12, 2010 at 3:00 p.m. Eastern Time at the Southampton Inn in Southampton, NY.
A live webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast.
An archived version of the webcast will be available for at least one week on the Investors section of the company's website at www.jazzpharmaceuticals.com.
About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals (Nasdaq: JAZZ) is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information see www.jazzpharmaceuticals.com.
SOURCE Jazz Pharmaceuticals, Inc.